Vanda Pharmaceuticals Inc. (VNDA)
After hours:
| Previous close | 4.84 |
| Open | 5.20 |
| Bid | 5.45 x 300 |
| Ask | 5.49 x 700 |
| Day's range | 5.17 - 5.95 |
| 52-week range | 3.30 - 6.92 |
| Volume | |
| Avg. volume | 2,434,350 |
| Market cap | 318.924M |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 137.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
UPDATE 3-Future Pak sweetens take-private offer for Vanda Pharmaceuticals
Privately held contract manufacturer Future Pak said on Tuesday it will sweeten its buyout offer for Vanda Pharmaceuticals to include contingent value rights, in addition to the proposed offer price of $7.25 to $7.75 per share in cash. The rights would provide additional benefits to Vanda shareholders if certain performance targets are met. Future Pak said the revised offer includes up to $260 million of potential contingent value rights, or CVR payments, and represents up to $4.37 per share in additional value for Vanda.
- Reuters
UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
Investment firm Shareholder Capital sent a letter to drugmaker Vanda Pharmaceuticals' board on Thursday asking it to reconsider Future Pak's takeover offer. Last week, Vanda rejected contract manufacturer Future Pak's offer of $7.25 to $7.75 per share in cash, which represents a 59%-70% premium to Wednesday's closing price, and adopted a shareholder rights plan to avert a hostile takeover attempt. Shareholder Capital, which owns 200,000 outstanding shares of Vanda, asked in its letter, "on what basis did the Board reject Future Pak's offer, which values Vanda shares at nearly 2x their unaffected price."
- Zacks
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
Vanda Pharmaceuticals (VNDA) reachead $4.56 at the closing of the latest trading day, reflecting a -1.51% change compared to its last close.
